Eris Lifesciences Limited (ERIS)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 314.58 411.29 409.71 324.41 341.30 456.69 428.75 399.73 404.77 578.64 650.50 315.29
YOY Revenue Growth % 11.5% 25.1% 15.29% -2.29% 8.49% 11.04% 4.65% 23.22% 18.6% 26.7% 51.72% -21.12%
Other Income 4.26 4.03 6.98 3.43 20.39 5.16 13.62 7.79 16.75 22.68 23.59 25.07
Total Income 318.84 415.31 416.68 327.85 361.69 461.85 442.37 407.52 421.52 601.32 674.09 340.36
Total Expenses + 179.47 208.85 216.74 209.09 214.34 227.19 191.79 192.01 380.34 445.06 439.42 321.80
Cost of Materials Consumed 25.07 26.17 28.64 23.75 17.74 24.40 23.19 10.93 9.83 24.12 20.29 17.05
Employee Benefit Expense 60.63 90.36 81.10 80.69 79.52 103.75 89.72 87.04 81.41 93.78 85.42 82.75
Other Expenses 93.77 92.32 107.00 104.65 117.08 99.04 78.88 94.04 78.07 87.02 70.81 45.16
Operating Profit 135.11 202.43 192.97 115.33 126.96 229.50 236.96 207.72 24.43 133.58 211.08 -6.51
OPM % 42.9% 49.2% 47.1% 35.5% 37.2% 50.3% 55.3% 52% 6% 23.1% 32.4% -2.1%
Profit Before Tax + 95.51 132.52 119.92 34.64 41.75 26.82 46.02 6.03 41.18 156.26 234.67 3.89
Tax Expense 7.67 21.78 2.11 2.99 2.24 9.78 17.92 4.25 10.71 56.27 85.10 0.80
Tax % 8% 16.4% 1.8% 8.6% 5.4% 36.5% 38.9% 70.5% 26% 36% 36.3% 20.6%
Profit After Tax 87.84 110.74 117.81 31.66 39.51 17.04 28.10 1.78 30.47 99.99 149.57 3.09
EPS (Basic) 6.46 8.14 8.66 2.33 2.90 1.25 2.06 0.13 2.24 7.34 10.98 0.23

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Revenue from Operations 1,697.75 1,486.71 1,330.73 1,215.73 1,108.83 1,020.23 896.54
YOY Revenue Growth % 14.2% 11.72% 9.46% 9.64% 8.68% 13.8% -
Other Income 35.51 34.83 17.26 28.99 10.00 14.73 32.50
Total Income 1,733.26 1,521.53 1,347.99 1,244.72 1,118.83 1,034.96 929.04
Total Expenses + 1,613.21 849.02 703.35 649.66 592.44 577.16 488.72
Cost of Materials Consumed 68.35 96.29 114.13 117.57 99.43 76.88 58.19
Employee Benefit Expense 361.92 331.67 252.52 222.18 207.02 191.73 166.77
Other Expenses 350.03 421.06 336.71 309.90 285.99 308.54 263.76
Operating Profit 84.54 637.68 627.37 566.07 516.40 443.07 407.82
OPM % 5% 42.9% 47.1% 46.6% 46.6% 43.4% 45.5%
Profit Before Exceptional 120.05 328.83 436.91 458.54 388.89 323.59 311.78
Exceptional Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 120.05 328.83 436.91 458.54 388.89 323.59 311.78
Tax Expense 42.66 29.12 38.90 41.35 38.29 32.32 26.40
Tax % 35.5% 8.9% 8.9% 9% 9.8% 10% 8.5%
Profit After Tax 77.39 299.71 398.01 417.19 350.61 291.27 285.38
EPS (Basic) 5.69 22.04 29.27 30.70 25.82 21.23 20.75

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
ASSETS
Non-Current Assets + 4,594.89 3,473.02 2,231.58 0.00 0.00 0.00 0.00
Property, Plant & Equipment 107.17 148.25 152.40 0.00 0.00 0.00 0.00
Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Non-Current Investments 991.27 1,618.95 966.52 0.00 0.00 0.00 0.00
Goodwill 48.57 20.00 16.66 0.00 0.00 0.00 0.00
Other Intangible Assets 2,256.44 1,347.31 728.75 0.00 0.00 0.00 0.00
Current Assets + 627.54 1,876.55 552.08 0.00 0.00 0.00 0.00
Inventories 191.25 91.64 63.70 0.00 0.00 0.00 0.00
Trade Receivables 236.19 239.97 229.22 0.00 0.00 0.00 0.00
Cash and Cash Equivalents 84.34 51.94 47.48 0.00 0.00 0.00 0.00
Current Investments 0.00 0.00 30.01 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Equity Share Capital 13.62 13.60 13.60 0.00 0.00 0.00 0.00
Other Equity 2,501.28 2,510.42 2,208.29 0.00 0.00 0.00 0.00
Non-Current Liabilities 1,713.59 563.77 278.00 0.00 0.00 0.00 0.00
Current Liabilities 993.94 2,261.78 283.77 0.00 0.00 0.00 0.00
Total Liabilities 2,707.53 2,825.55 561.77 0.00 0.00 0.00 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Cash from Operating Activities 701.87 336.29 322.33 369.41 0.00 0.00 0.00
Cash from Investing Activities -358.99 -2,491.89 -513.30 -267.64 0.00 0.00 0.00
Cash from Financing Activities -310.47 2,160.06 193.75 -88.42 0.00 0.00 0.00
Net Increase/Decrease in Cash 32.41 4.45 2.78 13.36 0.00 0.00 0.00